TORONTO, Feb. 1 /PRNewswire-FirstCall/ - Tm Bioscience Corporation , a leader in the commercial genetic testing market, today announced that Dr. Trevor L. Hawkins has resigned from the Company's Board of Directors, effective immediately.
"By sharing his deep understanding of the molecular diagnostics industry with us, Dr. Hawkins has significantly enhanced this company. Unfortunately, a change in employment and relocation to Europe has made it necessary for him to resign from our Board," said Greg Hines, President and CEO of Tm Biosciences. "On behalf of the Board of Directors and management team at Tm Bioscience, we thank Trevor and wish him the very best in his future endeavors."
About Tm Bioscience - Putting the Human Genome to Work(TM)
Tm Bioscience is a DNA-based diagnostics company developing a suite of genetic tests. Tm Bioscience's product pipeline includes tests for genetic disorders, drug metabolism, and infectious diseases. Tm Bioscience is located in Toronto, Ontario. Additional information about Tm Bioscience can be found at www.tmbioscience.com.
Forward-Looking Statements
This press release contains forward-looking statements, which by their nature necessarily involve risk and uncertainties that could cause the actual results to differ materially from those contemplated by such statements. Tm Bioscience considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions readers that these assumptions may ultimately prove to be incorrect due to certain risks and uncertainties including, without limitation, the difficulty of predicting regulatory approvals, market acceptance and demand for new products, the availability of appropriate genetic content and other materials required for Tm Bioscience's products, Tm Bioscience's ability to manufacture its products on a large scale, the protection of intellectual property connected with genetic content, the impact of competitive products, currency fluctuations, risks associated with Tm Bioscience's manufacturing facility and any other similar or related risks and uncertainties. If any of these risks or uncertainties were to materialize, or if assumptions underlying the forward- looking statements of management were to prove incorrect, actual results of Tm Bioscience could vary materially from those that are expressed or implied by these forward-looking statements. Tm Bioscience disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
The TSX Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
Tm BioscienceCONTACT: INVESTOR RELATIONS CONTACT: Tm Bioscience - James Smith, TheEquicom Group, Tel.: (416) 815-0700, Email: jsmith@equicomgroup.com; Torequest a free copy of this organization's annual report, please go tohttp://www.newswire.ca and click on Tools for Investors.
